These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24732)

  • 41. Regional distribution of enkephalin in bovine brain.
    Lindberg I; Smythe SJ; Dahl JL
    Brain Res; 1979 May; 168(1):200-4. PubMed ID: 222395
    [No Abstract]   [Full Text] [Related]  

  • 42. Degradation of met-enkephalin by extracts of various regions of the human brain: effects of antipsychotics and narcotics in vitro.
    Jakubovic A
    Peptides; 1982; 3(1):21-6. PubMed ID: 6123112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. K-stimulated release of leu- and met-enkephalin from rat striatal slices: lack of effect of morphine and naloxone.
    Richter JA; Wesche DL; Frederickson RC
    Eur J Pharmacol; 1979 Jun; 56(1-2):105-13. PubMed ID: 467501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidepressants inhibit enkephalin binding to synaptosome-enriched fractions of rat brain.
    Somoza E; Galindo A; Bazán E; Guillamón A; Valencia A; Fuentes JA
    Neuropsychobiology; 1981; 7(6):297-301. PubMed ID: 7312147
    [No Abstract]   [Full Text] [Related]  

  • 45. Conversion of [met5]-enkephalin-Arg6-Phe7 to [met5]-enkephalin by dipeptidyl carboxypeptidase.
    Yang HY; Majane E; Costa E
    Neuropharmacology; 1981 Sep; 20(9):891-4. PubMed ID: 7027075
    [No Abstract]   [Full Text] [Related]  

  • 46. Visual deprivation decreases met-enkephalin and substance P content of various forebrain structures.
    Pradelles P; Cros C; Humbert J; Dray F; Ben-Ari Y
    Brain Res; 1979 Apr; 166(1):191-3. PubMed ID: 421151
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro release of Leu- and Met-enkephalin from the corpus striatum.
    Henderson G; Hughes J; Kosterlitz HW
    Nature; 1978 Feb; 271(5646):677-9. PubMed ID: 24181
    [No Abstract]   [Full Text] [Related]  

  • 48. Changes in catalepsy and receptor sensitivity following chronic neuroleptic treatment.
    Allikmets LH; Zarkovsky AM; Nurk AM
    Eur J Pharmacol; 1981 Oct; 75(2-3):145-7. PubMed ID: 6119215
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of chronic striatal kainate lesions on some dopaminergic parameters and enkephalin immunoreactive neurons in the basal ganglia.
    Schwarcz R; Fuxe K; Hökfelt T; Terenius L; Goldstein M
    J Neurochem; 1980 Apr; 34(4):772-8. PubMed ID: 6102111
    [No Abstract]   [Full Text] [Related]  

  • 50. Enkephalin degradation in mouse brain studied by a new H.P.L.C. method: further evidence for the involvement of carboxydipeptidase.
    Guyon A; Roques BP; Guyon F; Foucault A; Perdrisot R; Swerts JP; Schwartz JC
    Life Sci; 1979 Oct; 25(18):1605-11. PubMed ID: 522617
    [No Abstract]   [Full Text] [Related]  

  • 51. Neuropeptide degrading enzyme(s) in plasma and brain: effects of in vivo neuroleptic administration.
    Traficante LJ; Turnbull B
    Pharmacol Res Commun; 1982 Apr; 14(4):341-8. PubMed ID: 6124980
    [No Abstract]   [Full Text] [Related]  

  • 52. Proteolysis of lipotropin C-fragment takes place extracellularly to form gamma-endorphin and [methionine]enkephalin [proceedings].
    Smyth DG; Snell CR
    Biochem Soc Trans; 1977; 5(5):1397-9. PubMed ID: 923941
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of perinatal lead administration on the ontogeny of striatal enkephalin levels in the rat.
    Winder C; Kitchen I; Clayton LB; Gardiner SM; Wilson JM; Lewis PD
    Toxicol Appl Pharmacol; 1984 Mar; 73(1):30-4. PubMed ID: 6710516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extremely rapid degradation of [3H] methionine-enkephalin by various rat tissues in vivo and in vitro.
    Dupont A; Cusan L; Garon M; Alvarado-Urbina G; Labrie F
    Life Sci; 1977 Oct; 21(7):907-14. PubMed ID: 927020
    [No Abstract]   [Full Text] [Related]  

  • 55. Cholecystokinin and enkephalin levels following ethanol administration in rats.
    Ryder S; Straus E; Lieber CS; Yalow RS
    Peptides; 1981; 2(2):223-6. PubMed ID: 7291043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioid peptide precursors in striatum.
    Beaumont A; Fuentes JA; Hughes H; Metters KM
    FEBS Lett; 1980 Dec; 122(1):135-7. PubMed ID: 7215540
    [No Abstract]   [Full Text] [Related]  

  • 57. Clozapine inhibition of metenkephalin binding to synaptosome-enriched fractions of rat whole brain and hippocampus.
    Somoza E; Franco C; Laviña M; Fuentes JA
    Neurochem Res; 1981 Apr; 6(4):413-24. PubMed ID: 7266749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amygdaloid kindling enhances the enkephalin content in the rat brain.
    Vindrola O; Briones R; Asai M; Fernández-Guardiola A
    Neurosci Lett; 1981 Jan; 21(1):39-43. PubMed ID: 7207869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enkephalin inactivation by N-terminal tyrosine cleavage: purification and partial characterization of a highly specific enzyme from human brain.
    Traficante LJ; Rotrosen J; Siekierski J; Tracer H; Gershon S
    Life Sci; 1980 May; 26(20):1697-706. PubMed ID: 7392806
    [No Abstract]   [Full Text] [Related]  

  • 60. Separation of enkephalin degradation products by ligand-exchange chromatography.
    Maurer R
    J Biochem Biophys Methods; 1980 Mar; 2(3):183-7. PubMed ID: 6999070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.